EndoRobotics
Korean maker of ROBOPERA, an add-on robotic platform that turns standard endoscopes into tools for incisionless gastrointestinal surgery.
EndoRobotics develops robotic and manual platforms for endoluminal therapy. Its ROBOPERA system attaches robotic manipulation to existing diagnostic endoscopes so that gastrointestinal lesions can be removed through a natural orifice without an incision, using single-use, procedure-specific instruments such as the TraCloser traction device; an endoscopic suturing device, RollingStitch, is in development, and EndoCubot is a training simulator. ROBOPERA received U.S. FDA 510(k) clearance in 2025, the company signed an exclusive global distribution agreement with Olympus in May 2026, and Korea's trade ministry determined on Oct 1, 2026 that its core technology falls under the National Core Technology framework.
- Latest funding
- —
- Total funding
- —
- Latest valuation
- —
- Founded
- —
- Country
- South Korea